Two Sigma Securities, LLC Forte Biosciences, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.48 - $0.85 $2,068 - $3,663
-4,310 Reduced 27.93%
11,122 $7,000
Q4 2023

Feb 14, 2024
BUY
$0.38 - $0.82 $5,864 - $12,654
15,432 New
15,432 $12,000
Q2 2022

Aug 15, 2022
BUY
$1.07 - $1.55 $16,521 - $23,933
15,441 New
15,441 $20,000
Q4 2021

Feb 14, 2022
SELL
$2.02 - $3.36 $39,091 - $65,022
-19,352 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.96 - $36.67 $57,281 - $709,637
19,352 New
19,352 $57,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email